News
Stories and articles featuring PCI, our partners, and Penn-affiliated spinout companies
Stories and articles featuring PCI, our partners, and Penn-affiliated spinout companies
Regenxbio's gene therapy would eliminate the need for wet AMD patients to visit their doctor every few months to receive a needle in their eye to treat their condition.
In a proof-of-concept study, microrobots effectively cleaned plaque and decay-causing bacteria from both mock and human teeth.
A major goal of this research is to help self-driving cars and other autonomous transportation systems achieve increased efficiency and performance, as well as better safety guarantees.
Learn about these cutting-edge new projects that are improving value-based medical care.
Penn Medicine ranked number two out of the top five large health systems, second only to Mayo Clinic in Rochester, MN.
Kelly is the CEO of Carisma Therapeutics, a PCI startup that provides cellular immunotherapy for solid tumors.
Learn about Marion Leary and her mission to help health professionals pursue a career path in innovation.
PCI Fellows get exposure to a wide range of emerging technologies and commercialization opportunities in the life sciences, physical sciences, nanotechnology, and beyond.
Twelve fellows were admitted to the 2022/2023 cohort out of a large application pool. We also have three returning Sr. fellows from last year.
The University of Pennsylvania led the region with 490 NCI grants totaling $234 million during this three year time period.